Irina Maric Selected Research

Irina Maric Research Topics

Disease

13	Neoplasms (Cancer) 01/2020 - 01/2010
11	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 01/2011
10	Multiple Myeloma 11/2021 - 01/2011
5	Smoldering Multiple Myeloma 11/2021 - 06/2014
5	Eosinophilia 01/2019 - 01/2008
5	Mastocytosis 12/2018 - 10/2009
4	Sickle Cell Anemia (Hemoglobin S Disease) 12/2015 - 08/2006
3	Systemic Mastocytosis 01/2022 - 01/2008
3	Residual Neoplasm 12/2021 - 01/2021
3	Disease Progression 01/2017 - 02/2015
3	Cytopenia 01/2016 - 06/2010
3	Leukemia 12/2013 - 02/2007
2	Hairy Cell Leukemia 12/2021 - 10/2020
2	Headache (Headaches) 01/2019 - 01/2016
2	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2019 - 01/2018
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2019 - 07/2018
2	Monoclonal Gammopathy of Undetermined Significance 01/2018 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 02/2016
2	Lymphoma (Lymphomas) 01/2017 - 06/2014
2	Lymphopenia (Lymphocytopenia) 02/2016 - 09/2011
2	Fibrosis (Cirrhosis) 01/2016 - 08/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016 - 08/2012
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2013 - 01/2011
2	Hyperplasia 04/2012 - 12/2011
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2012 - 11/2010
2	Fever (Fevers) 08/2010 - 11/2004
1	Cutaneous Mastocytosis 01/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2021
1	Thrombocytopenia (Thrombopenia) 10/2020
1	Hemorrhage 10/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020
1	Infantile Epileptic-Dyskinetic Encephalopathy 01/2020
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Immediate Hypersensitivity 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018
1	Autoimmune Lymphoproliferative Syndrome 01/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017
1	Circulating Neoplastic Cells 04/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2016
1	Hypersensitivity (Allergy) 02/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2016

Drug/Important Bio-Agent (IBA)

7	ibrutinibIBA 11/2020 - 02/2015
6	Chimeric Antigen ReceptorsIBA 01/2018 - 11/2010
4	Lenalidomide (CC 5013)FDA Link 11/2021 - 09/2015
4	carfilzomibIBA 11/2021 - 09/2015
3	Tryptases (Tryptase)IBA 01/2022 - 12/2015
3	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 09/2015
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020 - 04/2016
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2016
3	B-Cell Maturation AntigenIBA 01/2018 - 01/2016
3	Hydroxyurea (Hydrea)FDA LinkGeneric 11/2011 - 08/2006
2	Rituximab (Mabthera)FDA Link 12/2021 - 10/2020
2	Cladribine FDA LinkGeneric 12/2021 - 10/2020
2	purineIBA 12/2021 - 10/2020
2	Interleukin-5 (Interleukin 5)IBA 01/2019 - 11/2011
2	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2019 - 06/2015
2	AntibodiesIBA 07/2018 - 02/2016
2	Biomarkers (Surrogate Marker)IBA 03/2018 - 01/2017
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 09/2015
2	Proteasome InhibitorsIBA 01/2017 - 09/2015
2	Interleukin-7 (Interleukin 7)IBA 02/2016 - 01/2010
2	Fetal Hemoglobin (Hemoglobin F)IBA 01/2016 - 12/2015
2	Immunoglobulins (Immunoglobulin)IBA 11/2015 - 01/2011
2	Immunoglobulin M (IgM)IBA 06/2014 - 02/2006
2	Imatinib Mesylate (Gleevec)FDA Link 01/2008 - 11/2007
1	Omalizumab (Xolair)FDA Link 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	ofatumumab FDA Link 01/2021
1	serum P-component (CIt)IBA 01/2021
1	avelumabIBA 01/2021
1	fludarabineIBA 11/2020
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2019
1	benralizumabIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	aerolysinIBA 07/2018
1	Chromogranin AIBA 03/2018
1	DexpramipexoleIBA 01/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2018
1	SteroidsIBA 01/2018
1	Immunomodulating AgentsIBA 01/2017
1	CaspasesIBA 01/2017
1	alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA 01/2017
1	Chymotrypsin FDA Link 01/2017
1	TrypsinIBA 01/2017
1	Monoclonal AntibodiesIBA 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016

Therapy/Procedure

22	Therapeutics 01/2022 - 08/2006
3	Drug Therapy (Chemotherapy) 04/2012 - 11/2010
2	Hematopoietic Stem Cell Transplantation 04/2016 - 12/2013
1	Radiotherapy 01/2021
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2020
1	Cell Transplantation 01/2020
1	Subcutaneous Injections 01/2019